Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Physiomics ( (GB:PYC) ) just unveiled an announcement.
Physiomics plc has completed an oversubscribed WRAP Retail Offer, raising gross proceeds of £223,279.48 through the issue of 74,426,493 new ordinary shares at the same price as a previously announced placing. Together, the retail offer and placing constitute a conditional fundraise of £673,279.36 via 224,426,453 new shares, subject to shareholder approvals at a general meeting and admission of the new shares to trading on AIM.
The company has set an expected timetable, with the general meeting scheduled for 7 April 2026 and admission of the new ordinary shares to AIM targeted for 8 April 2026. On admission, the new shares from both the placing and WRAP Retail Offer will rank pari passu with existing ordinary shares, meaning existing and new investors will hold the same class of equity once the fundraise completes.
The most recent analyst rating on (GB:PYC) stock is a Sell with a £0.48 price target. To see the full list of analyst forecasts on Physiomics stock, see the GB:PYC Stock Forecast page.
Spark’s Take on GB:PYC Stock
According to Spark, TipRanks’ AI Analyst, GB:PYC is a Neutral.
The score is held back primarily by weak financial performance (ongoing losses and persistent cash burn), partially offset by a low-leverage balance sheet and some improvement in price trend. Valuation is constrained by negative earnings and lack of dividend support.
To see Spark’s full report on GB:PYC stock, click here.
More about Physiomics
Physiomics plc is a UK-based life sciences company specialising in modelling and simulation, biostatistics, data science and bioinformatics for biotech and pharmaceutical clients. Leveraging proprietary tools such as its Virtual Tumour technology, the company supports drug development from discovery through clinical studies, and counts Merck KGaA, Astellas, Bicycle Therapeutics, Numab Therapeutics and Cancer Research UK among its clients.
Average Trading Volume: 7,388,452
Technical Sentiment Signal: Hold
Current Market Cap: £1.59M
Find detailed analytics on PYC stock on TipRanks’ Stock Analysis page.